Stryker Corporation $SYK Shares Bought by Varma Mutual Pension Insurance Co

Key Points

• Varma Mutual Pension Insurance Co increased its stake in Stryker by 10.5% in Q4, buying 5,100 shares to hold 53,610 shares valued at $18.84 million, and institutional investors now own about 77.09% of the company.
• Stryker missed quarterly estimates, reporting EPS of $2.60 (vs. $2.98 expected) and revenue of $6.02 billion (vs. $6.34 billion expected), but set FY2026 guidance of $14.90–15.10 EPS while analysts retain a "Moderate Buy" consensus with an average target of $397.86.
• Director Ronda E. Stryker sold 250,000 shares for roughly $90.7 million (a 9.23% reduction in her position), and the company pays a quarterly dividend of $0.88 (annualized $3.52, ~1.2% yield).

Varma Mutual Pension Insurance Co grew its stake in shares of Stryker Corporation (NYSE:SYK - Free Report) by 10.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 53,610 shares of the medical technology company's stock after acquiring an additional 5,100 shares during the quarter. Varma Mutual Pension Insurance Co's holdings in Stryker were worth $18,842,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. United Financial Planning Group LLC acquired a new stake in Stryker during the 3rd quarter worth approximately $27,000. Strive Asset Management LLC acquired a new stake in Stryker during the 3rd quarter worth approximately $30,000. ANTIPODES PARTNERS Ltd acquired a new stake in Stryker during the 3rd quarter worth approximately $34,000. Copia Wealth Management increased its position in Stryker by 181.6% during the 3rd quarter. Copia Wealth Management now owns 107 shares of the medical technology company's stock worth $40,000 after purchasing an additional 69 shares in the last quarter. Finally, WPG Advisers LLC increased its position in Stryker by 156.8% during the 3rd quarter. WPG Advisers LLC now owns 113 shares of the medical technology company's stock worth $42,000 after purchasing an additional 69 shares in the last quarter. Institutional investors and hedge funds own 77.09% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the stock. Needham & Company LLC dropped their target price on shares of Stryker from $454.00 to $418.00 and set a "buy" rating for the company in a research report on Friday. Sanford C. Bernstein set a $410.00 target price on shares of Stryker in a research report on Friday. Wall Street Zen raised shares of Stryker from a "hold" rating to a "buy" rating in a research report on Saturday. TD Cowen downgraded shares of Stryker from a "buy" rating to a "hold" rating and set a $387.00 target price for the company. in a research report on Monday, January 26th. Finally, Citigroup lowered their price objective on shares of Stryker from $420.00 to $385.00 and set a "buy" rating for the company in a research report on Tuesday, April 7th. Sixteen investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat.com, Stryker currently has an average rating of "Moderate Buy" and an average target price of $397.86.

Stryker Stock Up 0.2%

Shares of NYSE:SYK opened at $295.43 on Monday. The company has a quick ratio of 1.25, a current ratio of 2.11 and a debt-to-equity ratio of 0.62. Stryker Corporation has a 52-week low of $294.55 and a 52-week high of $404.87. The company has a 50 day moving average of $345.67 and a two-hundred day moving average of $356.80. The company has a market capitalization of $113.15 billion, a price-to-earnings ratio of 34.19, a price-to-earnings-growth ratio of 1.73 and a beta of 0.80.

Stryker (NYSE:SYK - Get Free Report) last issued its quarterly earnings data on Thursday, April 30th. The medical technology company reported $2.60 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.98 by ($0.38). Stryker had a net margin of 13.20% and a return on equity of 23.42%. The firm had revenue of $6.02 billion during the quarter, compared to analyst estimates of $6.34 billion. During the same period last year, the business earned $2.84 EPS. The firm's revenue was up 2.6% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. As a group, analysts forecast that Stryker Corporation will post 14.89 earnings per share for the current fiscal year.

Stryker Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, April 30th. Stockholders of record on Tuesday, March 31st were paid a dividend of $0.88 per share. This represents a $3.52 annualized dividend and a dividend yield of 1.2%. The ex-dividend date was Tuesday, March 31st. Stryker's dividend payout ratio is 41.90%.

Insider Activity at Stryker

In other news, Director Ronda E. Stryker sold 250,000 shares of the stock in a transaction that occurred on Wednesday, February 4th. The stock was sold at an average price of $362.92, for a total transaction of $90,730,000.00. Following the completion of the transaction, the director directly owned 2,457,331 shares in the company, valued at approximately $891,814,566.52. This represents a 9.23% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Company insiders own 4.60% of the company's stock.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons' offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.